CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 153 filers reported holding CYMABAY THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.08 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $3,136,949 | +1727.3% | 132,809 | +574.6% | 0.01% | +500.0% |
Q1 2023 | $171,671 | -70.3% | 19,687 | -78.6% | 0.00% | -66.7% |
Q4 2022 | $577,498 | +175.0% | 92,105 | +53.4% | 0.00% | +200.0% |
Q3 2022 | $210,000 | +288.9% | 60,024 | +230.5% | 0.00% | – |
Q2 2022 | $54,000 | -58.5% | 18,162 | -19.8% | 0.00% | -100.0% |
Q4 2020 | $130,000 | -71.3% | 22,658 | -63.8% | 0.00% | -66.7% |
Q3 2020 | $453,000 | +1158.3% | 62,577 | +514.5% | 0.01% | +500.0% |
Q2 2020 | $36,000 | – | 10,183 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management III, LLC | 1,641,804 | $11,887,000 | 8.85% |
Foresite Capital Management IV, LLC | 1,787,094 | $12,939,000 | 2.92% |
Copernicus Capital Management, LLC | 278,416 | $2,016,000 | 1.92% |
Sio Capital Management, LLC | 1,159,236 | $8,393,000 | 1.66% |
ACUTA CAPITAL PARTNERS, LLC | 765,000 | $5,539,000 | 1.50% |
Avoro Capital Advisors LLC | 10,300,000 | $74,572,000 | 1.06% |
Boxer Capital, LLC | 4,000,000 | $28,960,000 | 1.00% |
Vivo Capital, LLC | 2,089,356 | $15,127,000 | 0.87% |
EAM Global Investors LLC | 284,534 | $2,060,000 | 0.76% |
Versant Venture Management, LLC | 543,753 | $3,937,000 | 0.72% |